Targeting EGFR in glioblastoma: Beyond TKI and ACT IV

Date 10 September 2017
Event ESMO 2017 Congress
Session Targeted therapy in neuro-oncology
Topics Drug Development
Central Nervous System Malignancies
Presenter Michael Weller
Authors M. Weller
  • Department Of Neurology, Universitätsspital Zürich, 8091 - Zürich/CH